12/6/2019  9:59:42 PM Chg. -0.86 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
35.66USD -2.35% 7,248
Turnover: 259,064.29
-Bid Size: - -Ask Size: - 19.97 bill.USD - -

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Rice Powell
Management board
Helen Giza (ab 1.11.2019), Michael Brosnan (bis 31.10.2019), Dr. Katarzyna Mazur-Hofsäß, Dr. Olaf Schermeier, Frank Maddux (ab 1.01.2020), Harry de Wit, Kent Wanzek, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon, William P. Johnston
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 53.51%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR Fax: -
IR e-mail: ir@fmc-ag.com

Main Shareholders